JUN 22, 2019 10:27 AM PDT

Progress on a Potential Drug for Inflammatory Disease

WRITTEN BY: Carmen Leitch

A team of researchers is trying to develop a treatment for chronic inflammatory disorders by inhibiting a complex called the NLRP3 inflammasome, which is an important player in inflammation. An inhibitory molecule has already been created - MCC950; now researchers have demonstrated how it works, moving the drug one step closer to the clinic. The findings have been reported in Nature Chemical Biology and are outlined in the following video.

Inflammation is an important part of the body’s natural response to injury and microbial infection. But it has to be controlled carefully; too much inflammation can cause health problems and disease.

"Inflammation helps our bodies heal following infection, but when the inflammasome is not switched off, inflammation becomes damaging," said one of the study leaders, Dr. Rebecca Coll of the Institute for Molecular Bioscience at the University of Queensland (UQ). "Uncontrolled inflammation results in chronic diseases, such as Parkinson's disease, Alzheimer's disease, and respiratory diseases such as asthma."

"We previously identified a small molecule, MCC950, that inhibits the inflammasome to block inflammation in disease but, until now, we did not understand how it worked," explained another study leader, Associate Professor Kate Schroder of UQ's Institute for Molecular Bioscience. "We discovered that MCC950 binds directly to the inflammasome and inactivates it, turning off inflammation. Now that we understand how a small molecule can inhibit the inflammasome, we are very excited about the potential of inflammasome inhibitors as anti-inflammatory drugs."

In this work, the researchers found that MCC950 interacts with a very specific part of one domain of NLRP3, the Walker B motif. In doing so, it halts the formation of the inflammasome by preventing the hydrolysis of ATP.

Related: Getting Rid of Damaged Mitochondria Relieves Autoimmune Disease in Mice

"UQ start-up Inflazome Ltd, which is developing targeted therapies for inflammatory diseases, had announced its plans to commence clinical trials of their inflammasome inhibitors in 2019, and other companies are competing in this space," added study co-leader Professor Avril Robertson of UQ's School of Chemistry and Molecular Biosciences. "We are keen to see results of these trials and hope that our discovery can lead to the efficient design of new molecules as anti-inflammatory drugs of the future."

Sources: AAAS/Eurekalert! via UQ, Nature Chemical Biology

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 19, 2020
Cell & Molecular Biology
JAN 19, 2020
Rapamycin Can Prevent Age-related Memory Problems and Loss of Cerebral Blood Flow
Scientists have found that a drug called rapamycin can help restore blood flow to the brain that is lost during aging....
JAN 19, 2020
Cell & Molecular Biology
JAN 19, 2020
Insulin Can Help Stop the Spread of Viruses by Triggering a Mosquito Immune Pathway
There are no treatments for dengue, West Nile and Zika viruses, but researchers may have found a way to reduce the chance that they will spread....
JAN 19, 2020
Genetics & Genomics
JAN 19, 2020
Understanding How Loose RNA Molecules Help Rejuvenate Skin
This work may help develop new treatments for skin that is aging or damaged by wounds or burns....
JAN 19, 2020
Microbiology
JAN 19, 2020
Scientists Find the Limits of Life in an Extreme Environment
Different forms of microbes have been able to make a home even in the harshest conditions. But there are still locations where they can't live....
JAN 19, 2020
Cell & Molecular Biology
JAN 19, 2020
A Critical Step in Ribosome Assembly is Viewed For the First Time
Proteins are critical to biology, and are generated by vital, ancient cellular structures called ribosomes....
JAN 19, 2020
Cell & Molecular Biology
JAN 19, 2020
Scientists Reverse Cognitive Defects in Down Syndrome Mouse Model
Researchers have found a drug that can correct the memory and learning impairments that are linked to Down syndrome....
Loading Comments...